Detalles de la búsqueda
1.
Phase I dose escalation study and pilot efficacy analysis of LXI-15029, a novel mTOR dual inhibitor, in Chinese subjects with advanced malignant solid tumors.
BMC Cancer
; 23(1): 1200, 2023 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38057772
2.
Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib.
Chin J Cancer Res
; 35(5): 526-535, 2023 Oct 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37969958
3.
Preoperative versus postoperative chemo-radiotherapy for locally advanced gastric cancer: a multicenter propensity score-matched analysis.
BMC Cancer
; 22(1): 212, 2022 Feb 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35219300
4.
[Clinical characteristics of digestive system cancers metastatic to the heart].
Zhonghua Zhong Liu Za Zhi
; 44(11): 1229-1232, 2022 Nov 23.
Artículo
en Zh
| MEDLINE | ID: mdl-36380673
5.
[Value of tumor growth rate in evaluating the early therapeutic efficacy of neuroendocrine neoplasm].
Zhonghua Yi Xue Za Zhi
; 102(14): 1000-1006, 2022 Apr 12.
Artículo
en Zh
| MEDLINE | ID: mdl-35399019
6.
Anlotinib Monotherapy for Refractory Metastatic Colorectal Cancer: A Double-Blinded, Placebo-Controlled, Randomized Phase III Trial (ALTER0703).
Oncologist
; 26(10): e1693-e1703, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34105207
7.
Efficacy and safety of anlotinib in patients with advanced malignancy: a single-center, single-arm, phase 2 trial.
Int J Clin Oncol
; 26(9): 1611-1618, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34297245
8.
[The Chinese guidelines for the diagnosis and treatment of pancreatic neuroendocrine neoplasms (2020)].
Zhonghua Wai Ke Za Zhi
; 59(6): 401-421, 2021 Jun 01.
Artículo
en Zh
| MEDLINE | ID: mdl-34102722
9.
Down-staging depth score could be a survival predictor for locally advanced gastric cancer patients after preoperative chemoradiotherapy.
Chin J Cancer Res
; 33(4): 447-456, 2021 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34584370
10.
Surufatinib in advanced pancreatic neuroendocrine tumours (SANET-p): a randomised, double-blind, placebo-controlled, phase 3 study.
Lancet Oncol
; 21(11): 1489-1499, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32966810
11.
Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study.
Lancet Oncol
; 21(11): 1500-1512, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32966811
12.
Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial.
J Gastroenterol Hepatol
; 35(8): 1307-1316, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31900959
13.
Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study.
Br J Cancer
; 119(5): 538-545, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29755117
14.
A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer.
BMC Cancer
; 18(1): 803, 2018 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30089457
15.
Safety and Efficacy of the S-1/Temozolomide Regimen in Patients with Metastatic Neuroendocrine Tumors.
Neuroendocrinology
; 106(4): 318-323, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-28817826
16.
[Data review and analysis of 22 cases of gastric cancer associated with pregnancy].
Zhonghua Zhong Liu Za Zhi
; 40(8): 631-635, 2018 Aug 23.
Artículo
en Zh
| MEDLINE | ID: mdl-30139036
17.
Diagnosis, treatment, and prognosis of bronchopulmonary carcinoid: an analysis of 74 patients.
Anticancer Drugs
; 27(1): 54-9, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26398932
18.
[Relationship between treatment-related hypertension and therapeutic efficacy of vascular endothelial growth factor receptor tyrosine kinase inhibitors in metastatic renal cell carcinoma].
Zhonghua Zhong Liu Za Zhi
; 38(9): 698-702, 2016 Sep 23.
Artículo
en Zh
| MEDLINE | ID: mdl-27647404
19.
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 16(6): 619-29, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25981818
20.
Phase I dose-finding study of sorafenib with FOLFOX4 as first-line treatment in patients with unresectable locally advanced or metastatic gastric cancer.
Chin J Cancer Res
; 27(3): 239-46, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26157320